We are a clinical-stage AI-immunology™ platform company using our proprietary artificial intelligence, or AI, technology, engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop novel immunotherapies for the treatment of various cancers, bacterial diseases and viral infections. We are currently in the clinic with our two lead product candidates, EVX-01 and EVX-02, for the treatment of various cancers. We have three proprietary AI platforms: PIONEER, our immuno-oncology platform, EDEN, our bacterial disease platform, and RAVEN, our viral disease platform.